Pelvic radiation disease: ask an expert

Written in association with: Dr Shameer Mehta
Published:
Edited by: Cal Murphy

Cancer treatment has come a long way. Nowadays, many cancers can be treated successfully with techniques such as chemotherapy or radiotherapy. However, for some patients, radiotherapy can have some less-than-pleasant side-effects that linger long after the treatment. Dr Shameer Mehta is here to explain pelvic radiation disease (PRD).

What is pelvic radiation disease (PRD)?

Patients with cancer of the abdomen and pelvis are often treated with radiotherapy. This treatment, either alone or in combination with surgery or chemotherapy, is becoming more successful, meaning that patients are living for longer than ever before.

This is obviously fantastic news, but unfortunately, up to half of these patients will suffer with long-term gut symptoms affecting their quality of life as a direct result of their cancer treatment. These symptoms include diarrhoea, bloating, flatulence and rectal bleeding. This is a hugely under-recognised problem, sometimes because patients don’t report these symptoms to their cancer teams as they’re not aware that anything can be done about them.

These long-term gut complaints come about as a direct result of damage to the bowel from previous radiotherapy, and can occur some years after the treatment has ended.

 

Why is it associated with cervical cancer treatment?

Many women with cervical cancer are treated with radiotherapy, which is very effective at targeting cancerous tissue. However, the small intestine can dip down into the pelvis from the abdomen, meaning some parts can fall within the radiotherapy field. For this reason, parts of the small intestine can become damaged inadvertently, causing symptoms such as diarrhoea, pain and bloating, as well as reduced absorption of important nutrients.

In addition, the lower end of the large bowel (the rectum) is also located close to radiotherapy fields for cervical cancer. Damage of the lining of the rectum, close to the anus, can cause bleeding from a condition called radiation proctopathy. This is not a serious condition at all, and in most cases does not require treatment. In some patients with heavy or recurrent bleeding despite measures to regulate their bowel habits, I usually offer sucralfate enemas or newer endoscopic treatments.

 

Can PRD be avoided during cervical cancer treatment?

Much research has focused on whether PRD can be avoided completely and how. Unfortunately, there is no good quality evidence to show that any one therapy or strategy reduces the risk of developing PRD, apart from radiotherapy techniques such as conformal radiotherapy which are already widely used. Some evidence suggests increasing dietary fibre may help, but further research is required in this area. Similarly, probiotics may help reduce the severity of PRD symptoms, but it is not clear which probiotic preparation is the most effective for all patients. In general, ensuring your nutritional health is as good as it can be when undergoing radiotherapy is likely to help reduce the likelihood of developing PRD.

 

How can you manage PRD?

Often, the effects of cancer treatments such as radiotherapy on the bowel are irreversible. However, a number of gut conditions can occur as a result of these treatments, which themselves lead to unpleasant symptoms. These conditions are entirely benign and not worrying at all, but need to be given specific consideration if they are to be tested for and treated appropriately. These include, but are not limited to, conditions termed bile salt diarrhoea, small intestinal bacterial overgrowth, pancreatic insufficiency and radiation proctopathy. The specific treatments for these are usually very effective at improving symptoms and patients’ overall quality of life.

 

Visit Dr Mehta’s Top Doctors profile to book an appointment.

By Dr Shameer Mehta
Gastroenterology

Dr Shameer Mehta is a highly skilled and experienced gastroenterologist, based in London and specialising in pelvic radiation disease, inflammatory bowel disease (IBD) and nutritional disorders, among others.

He is one of only a few consultants who has been appointed to two London teaching hospitals: University College London Hospital and, currently, The Royal London Hospital (Barts Health NHS Trust) where he is the clinical lead for nutrition. His private practice is based at The London Digestive Centre and The Princess Grace Hospital, as well as Cleveland Clinic London where is also the clinical lead for nutrition. He maintains a strong interest in research and education, both nationally and internationally and is an honorary associate professor at University College London. He is also a passionate advocate for shared decision making between patient and physician and believes a healthy gut is vital for overall well-being. 

He began his medical training at Guy’s and St Thomas’s Hospitals, before starting his higher specialist training in North East London in gastroenterology. Following this, he then went on to complete a fellowship at Queen Mary’s and the Blizard Institute in medical education and basic science research. He was designated a fellow of the Higher Education Academy in recognition of his work. His research degree (MD) in basic science examined the role that microRNAs have in the control of the epithelial to mesenchymal transition and the development of intestinal fibrosis in Chron’s disease. 

Dr Mehta’s main role is as the Lead for the Intestinal Failure Service at The Royal London Hospital, one of the largest such services in the UK. He works in a multi-disciplinary fashion providing a comprehensive treatment plan to patients with complex nutritional care and intestinal failure. He also works with patients experiencing inflammatory bowel disease (IBD), irritable bowel disease and those with gastrointestinal disorders as a consequence of their cancer treatment. He currently holds the position of clinical lead for the trust’s Nutrition and Hydration Strategy Group, which attempts to improve nutritional provisions for patients, visitors and staff. 

He has a track record of delivering high-quality research in areas including the role malnutrition in IBD, intestinal-failure associated liver disease, and pelvic radiation disease. He is invited regularly to present his findings at conferences and seminars globally and continues to publish in high-impact  medical journals.   

Dr Mehta contributes to medical education as an accredited trainer for the ESPEN Clinical Nutrition Diploma, co-chairing the UCL Master’s degree in Clinical Nutrition and Public Health, and sits on the organising committee for the UCL postgraduate course in Clinical Nutrition.  

View Profile

Overall assessment of their patients


  • Related procedures
  • Nutrition
    Food intolerance test
    Eating disorders
    Depression
    Balloon enteroscopy
    pH monitoring
    Stomach reduction
    Gastric balloon
    Colon cleanse
    Gastroscopy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.